SESEN BIO INC (SESN)

US8177631053 - Common Stock

0.6288  +0.04 (+7.29%)

After market: 0.5832 -0.05 (-7.25%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2022-9-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
60.00M26.54M11.24M0.000.00
Operating Expenses
30.21M-2.13M32.31M108.49M34.50M
Research and Development
49.44M25.31M29.19M24.66M14.08M
Selling, General, and Administrative Expenses
50.28M29.39M14.30M12.21M11.62M
Operating Income
29.79M28.68M-21.08M-108.49M-34.50M
Interest Income/Expense
N/AN/AN/AN/A0.00
Other Income/Expense
880.00K-60.00K130.00K990.00K810.00K
Non Recurring Items
N/A-37.23MN/AN/AN/A
Income Before Taxes
-8.05M-8.61M-20.95M-107.50M-33.69M
Income Tax
-3.88M-8.27M1.45MN/A0.00
Net Income
-4.17M-336.00K-22.54M-107.50M-33.69M
EBITDA
N/A28.76M-20.96M-108.27M-34.29M
 
Per Share Data
EPS Diluted Total Ops
-0.02-0.00-0.19-1.18-0.55
Non GAAP EPS
-1.16-0.10-0.23-1.20-0.54
 
Statistics
Profit Margin
-6.96%-1.27%-200.53%N/AN/A
Operating Profit Margin
49.65%108.04%-187.54%N/AN/A

All data in USD

Charts